In summer 2015, BU launched the BU Bridging Fund Scheme to
provide ‘bridging funding’ for the continuation of employment of research staff for a short-term (usually up to three months, but up to six months can be considered in exceptional situations) between research grants. BU’s Bridging Fund Scheme is intended to permit the temporary employment, in certain circumstances, of researchers between fixed-term contracts at BU, for whom no other source of funding is available, in order to:
(a) encourage the retention of experienced and skilled staff, and sustain research teams and expertise;
(b) avoid the break in employment and career which might otherwise be faced by such staff;
(c) maximise the opportunity for such staff to produce high-quality outputs and/or research impact at the end of funded contracts/grants.
The scheme guidelines have been updated to include a figure demonstrating the application workflow (in Appendix 2 of the scheme guidelines).
The Bridging Fund Scheme is an action from our Athena Swan action plan (which aims to create a more gender inclusive culture at BU) and our HR Excellence in Research Award (which aims to increase BU’s alignment with the national Concordat to Support the Career Development of Researchers).
BU Bridging Fund Scheme – updated
Reminder about the BU Bridging Fund










BU contributions to successful Global Health conference
New paramedic science paper by BU’s Dr. Ursula Rolfe
Congratulation on newly published systematic review
Equitable Partnerships in Global Health Research
Horizon Europe Cluster 3 (Civil Security for Society) 2026 Calls Now Open
MSCA Doctoral Networks 2026 Call Information Webinar
ESRC Festival of Social Science 2026: Application Deadline Extended to Thursday 25 June 2026
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease